İçeriğe geç
akaturk Akademik ölçüm

Makale detayı · 2022

Catch-up Growth and Discontinuation of Fludrocortisone Treatment in Aldosterone Synthase Deficiency.

The Journal of clinical endocrinology and metabolism

YÖKSİS OpenAlex Açık erişim · bronze SJR Q1 JCR Q1 Atıf 11 Yüzdelik 77.7% FWCI 1.08
Yıl
2022
ISSN
0021-972X
Tür
article

Veri kaynağı ayrımı

  • YÖKSİS YÖKSİS makale kaydı
  • OpenAlex OpenAlex zenginleştirmesi (özet, atıf, konular)

Özet

İngilizce (OpenAlex)

BACKGROUND: Aldosterone synthase deficiency (ASD) caused by mutations in the CYP11B2 gene is characterized by isolated mineralocorticoid deficiency. Data are scarce regarding clinical and biochemical outcomes of the disease in the follow-up. OBJECTIVE: Assessment of the growth and steroid profiles of patients with ASD at the time of diagnosis and after discontinuation of treatment. DESIGN AND METHOD: Children with clinical diagnosis of ASD were included in a multicenter study. Growth and treatment characteristics were recorded. Plasma adrenal steroids were measured using liquid chromatography-mass spectrometry. Genetic diagnosis was confirmed by CYP11B2 gene sequencing and in silico analyses. RESULTS: Sixteen patients from 12 families were included (8 females; median age at presentation: 3.1 months, range: 0.4 to 8.1). The most common symptom was poor weight gain (56.3%). Median age of onset of fludrocortisone treatment was 3.6 months (range: 0.9 to 8.3). Catch-up growth was achieved at median 2 months (range: 0.5 to 14.5) after treatment. Fludrocortisone could be stopped in 5 patients at a median age of 6.0 years (range: 2.2 to 7.6). Plasma steroid profiles revealed reduced aldosterone synthase activity both at diagnosis and after discontinuation of treatment compared to age-matched controls. We identified 6 novel (p.Y195H, c.1200 + 1G > A, p.F130L, p.E198del, c.1122-18G > A, p.I339_E343del) and 4 previously described CYP11B2 variants. The most common variant (40%) was p.T185I. CONCLUSIONS: Fludrocortisone treatment is associated with a rapid catch-up growth and control of electrolyte imbalances in ASD. Decreased mineralocorticoid requirement over time can be explained by the development of physiological adaptation mechanisms rather than improved aldosterone synthase activity. As complete biochemical remission cannot be achieved, a long-term surveillance of these patients is required.

Konular

  • Hormonal Regulation and Hypertension
  • Ion Transport and Channel Regulation
  • Renin-Angiotensin System Studies

Birincil konu Hormonal Regulation and Hypertension

Yazarlar

  1. BUŞRA GÜRPINAR TOSUN
  2. YASEMİN KENDİR DEMİRKOL
  3. TUBA SEVEN MENEVŞE
  4. SARE BETÜL KAYGUSUZ
  5. MEHMET NURİ ÖZBEK
  6. SELDA AYÇA ALTINCIK
  7. Jamala Mammadova
  8. ATİLLA ÇAYIR ATATÜRK ÜNİVERSİTESİ
  9. ESRA DÖĞER
  10. ELVAN BAYRAMOĞLU
  11. ÖZLEM NALBANTOĞLU
  12. RAHİME GÜL YEŞİLTEPE MUTLU KOÇ ÜNİVERSİTESİ
  13. AGHARZA AGHAYEV
  14. SERAP DEMİRCİOĞLU
  15. ABDULLAH BEREKET MARMARA ÜNİVERSİTESİ
  16. TÜLAY GÜRAN
  17. ZERRİN ORBAK ATATÜRK ÜNİVERSİTESİ